Submitted by Anonymous (not verified) on 17 March 2026 - 16:42
Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Date of authorisation: 13/01/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Date of authorisation: 13/01/2025, Revision: 3, Status: Authorised